Sfoglia per Autore
Cytotoxic chemotherapy for adrenocortical carcinoma.
1995-01-01 L., Dogliotti; Berruti, Alfredo; Pia, A; Paccotti, P; Alì, A; Angeli, A.
Third-line chemotherapy with mitomycin C and lonidamine in advanced bladder cancer. Partial response in a patient with skin and lung metastases.
1995-01-01 Berruti, Alfredo; Gerbino, A; Faggiuolo, R; Rovero, E; Dogliotti, L.
Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients.
1996-01-01 Bretti, S; Berruti, Alfredo; Gorzegno, G; LA CIURA, P; Pazè, E; Celano, A; Grecchi, G; Perroni, D; Bumma, C; Dogliotti, L.
Serum and urinary profile of bone turnover markers in a patient with tamoxifen induced hypercalcemia submitted to pamidronate therapy
1996-01-01 Berruti, Alfredo; Torta, M; Piovesan, P; Sperone, P; Dogliotti, L; Angeli, A.
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial.
1996-01-01 L., Dogliotti; Berruti, Alfredo; Buniva, T.; Zola, P.; Bau, M. G.; Farris, A.; Sarobba, M. G.; Bottini, A.; Alquati, P.; Deltetto, F.; Gosso, P.; Monzeglio, C.; Moro, G.; Sussio, M.; Perroni, D.
Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension.
1996-01-01 Berruti, Alfredo; Piovesan, A.; Torta, M.; Raucci, C. A.; Gorzegno, G.; Paccotti, P.; Dogliotti, L; Angeli, A.
Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours.
1996-01-01 Bottini, A; Berruti, Alfredo; Bersiga, A; Brunelli, A; Brizzi, Mp; Marco, Bd; Cirillo, F; Bolsi, G; Bertoli, G; Alquati, P; L., Dogliotti
Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
1997-01-01 Berruti, Alfredo; Tampellini, M; Gorzegno, G; L., Dogliotti
Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.
1997-01-01 Tampellini, M; Berruti, Alfredo; Gerbino, A; Buniva, T; Torta, M; Gorzegno, G; Faggiuolo, R; Cannone, R; Farris, A; Destefanis, M; Moro, G; Deltetto, F; Dogliotti, L.
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P).
1997-01-01 Berruti, Alfredo; Cerutti, S; Fasolis, G; Sperone, P; Tarabuzzi, R; Bertetto, O; Pagani, G; Zolfanelli, R; Pallotti, S; Bumma, C; Fontana, D; Rosseti, Sr; Dogliotti, L; Angeli, A.
Pamidronate administration improves the secondary hyperparathyroidism due to 'Bone Hunger Syndrome' in a patient with osteoblastic metastases from prostate cancer.
1997-01-01 Berruti, Alfredo; P., Sperone; G., Fasolis; M., Torta; D., Fontana; L., Dogliotti; A., Angeli
Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival.
1997-01-01 Berruti, Alfredo; Zola, P; Buniva, T; Baù, Mg; Farris, A; Sarobba, Mg; Bottini, A; Tampellini, M; Durando, A; Destefanis, M; Monzeglio, C; Moro, G; Sussio, M; Perroni, D; Dogliotti, L.
Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone disease.
1997-01-01 Piovesan, A; Berruti, Alfredo; Torta, M; Cannone, R; Sperone, P; Panero, A; Gorzegno, G; Termine, A; Dogliotti, L; Angeli, A.
Influence of neoadjuvant chemotherapy on serum tumor markers CA 15-3, MCA, CEA, TPS and TPA in breast cancer patients with operable disease.
1997-01-01 Bottini, A; Berruti, Alfredo; Tampellini, M; Morrica, B; Brunelli, A; Gnocchi, E; Brizzi, Mp; Aguggini, S; Fara, E; Alquati, P; L., Dogliotti
Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
1998-01-01 Berruti, Alfredo; M., Terzolo; A., Pia; A., Angeli; L., Dogliotti
Randomized comparison of goserelin acetate versus mitomycin C plus goserelin acetate in previously untreated prostate cancer patients with bone metastases
1998-01-01 Fontana, D; Bertetto, O; Fasolis, G; Berruti, Alfredo; Tarabuzzi, R; Pagani, G; Buniva, T; Zolfanelli, R; Pallotti, S; Frezzotti, L; Bumma, C; Rossetti, Sr; Dogliotti, L.
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study.
1998-01-01 Dogliotti, L; Danese, S; Berruti, Alfredo; Zola, P; Buniva, T; Bottini, A; Richiardi, G; Moro, G; Farris, A; Baù, Mg; Porcile, G.
Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare Tumors.
1998-01-01 Bretti, S; Berruti, Alfredo; Dogliotti, L; Castagneto, B; Bertulli, R; Spadaro, P; Toscano, G; Astorre, P; Verusio, C; Lionetto, R; Bruzzi, P; Santoro, A.
Rationale for the use of bisphosphonates in the treatment of bone disease induced by prostate cancer
1998-01-01 Dogliotti, L.; Berruti, Alfredo; Gorzegno, G.; Bitossi, R.; Angeli, A.
Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patients.
1998-01-01 Bottini, A; Berruti, Alfredo; Bersiga, A; Brunelli, A; Brizzi, Mp; DI MARCO, B; Cirillo, F; Tampellini, M; Bolsi, G; Aguggini, S; Betri, E; Filippini, L; Bertoli, A; Alquati, P; L., Dogliotti
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile